MPG.eBooks - Description: Long-term use of ondansetron, dolasetron, and granisetron for the prevention of nausea and vomiting

Cover Image

Read Now

Long-term use of ondansetron, dolasetron, and granisetron for the prevention of nausea and vomiting a review of the clinical effectiveness and safety

The purpose of this review is to provide evidence on the comparative clinical effectiveness and safety of the long-term use (> 5 days) of serotonin receptor antagonists (5-HT3RAs) for the prevention of nausea and vomiting

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2014, 23 April 2014
Series:	Rapid response report: summary with critical appraisal
Subjects:	Nausea / Prevention & Control Canada Ondansetron / Therapeutic Use Treatment Outcome Indoles / Therapeutic Use Granisetron / Therapeutic Use Vomiting / Prevention & Control
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK269203
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The purpose of this review is to provide evidence on the comparative clinical effectiveness and safety of the long-term use (> 5 days) of serotonin receptor antagonists (5-HT3RAs) for the prevention of nausea and vomiting
Item Description:	Title from PDF caption title. - "CADTH Rapid Response Service."
Physical Description:	1 PDF file (7 pages) illustrations